I feel like I’ve been in this exact place, saying exactly what I’m saying right now. Have I done this in a past life? Did I dream it and am now subconsciously acting it out in reality? Or is my brain performing a fact-check on its memory system and signaling it with the sensation known […] The post There’s comfort in putting a name to a multiple sclerosis symptom appeared first on Multiple Sclerosis News Today ..read more

Among immigrants to Canada, the risk of multiple sclerosis (MS) is higher for those who have spent a greater portion of their life in Canada, a new study reports. The study, “Proportion of Life Spent in Canada and the Incidence of Multiple Sclerosis in Permanent Immigrants,” was published in Neurology. In wealthy countries such as […] The post Immigrants to Canada see MS risk rising with time in country: Study appeared first on Multiple Sclerosis News Today ..read more

Canada has one of the world’s highest rates of multiple sclerosis (MS) in the world, and this month residents are being urged to come together to raise awareness of and funds for people affected by the neurodegenerative disorder. May is Multiple Sclerosis Awareness Month in Canada, and MS Canada is inviting supporters to participate in any […] The post MS Canada seeks nationwide participation in awareness month appeared first on Multiple Sclerosis News Today ..read more

What’s a reliable way to wreck your mood? Fighting your circadian rhythms. I’m a recovering night owl. I used to get more done between 10 p.m. and 2 a.m. than I did in the other 20 hours of the day. I routinely studied past 2 a.m. during college and medical school, cramming in massive amounts […] The post Why we should go with the flow of our biological clocks appeared first on Multiple Sclerosis News Today ..read more

A committee of the European Medicines Agency (EMA) is recommending the approval of a subcutaneous, or under-the-skin, formulation of Ocrevus (ocrelizumab) for people with multiple sclerosis (MS) in the European Union. The Committee for Medicinal Products for Human Use, known as CHMP, specifically recommended that this new formulation — designed to ease the treatment burden […] The post Committee favors approval of under-the-skin Ocrevus in Europe appeared first on Multiple Sclerosis News Today ..read more

NKTR-0165, an antibody that targets the tumor necrosis factor receptor type 2 (TNFR2), will continue to be developed by Nektar Therapeutics as a candidate for treating multiple sclerosis (MS) and other autoimmune diseases. The experimental therapy was developed under a 2021 collaboration between Nektar and Biolojic Design, which set out to design and test antibodies […] The post Nektar to develop NKTR-0165 for MS, autoimmune diseases appeared first on Multiple Sclerosis News Today ..read more

A specialized imaging approach was able to detect signs of persistent inflammation in the brains of people with multiple sclerosis (MS) that aren’t readily captured by standard MRI scans. This so-called smoldering inflammation was also observed among those patients taking high-efficacy disease-modifying therapies (DMTs), where a higher degree of it was associated with greater disability […] The post Specialized PET scan shows chronic inflammation tied to MS progression appeared first on Multiple Sclerosis News Today ..read more

A lower dose of the experimental oral therapy vidofludimus calcium (IMU-838) was not as effective as higher doses at reducing lesions in people with relapsing-remitting multiple sclerosis (RRMS), extended data from the therapy’s Phase 2 EMPhASIS trial show. “We found that doses of 30 mg and 45 mg, but not 10 mg, suppressed new MRI […] The post Lower vidofludimus calcium dose not as effective in RRMS trial appeared first on Multiple Sclerosis News Today ..read more

For people who develop multiple sclerosis (MS), the disease can exact a toll on their ability to work and on how much they earn in the private sector, according to a study by researchers in France, who said policies need to be enacted to replace lost income. “The effects of MS on the employed population […] The post Employment, income drop steadily over 2 decades after onset of MS appeared first on Multiple Sclerosis News Today ..read more

What’s a reliable way to wreck your mood? Fighting your circadian rhythms. I’m a recovering night owl. I used to get more done between 10 p.m. and 2 a.m. than I did in the other 20 hours of the day. I routinely studied past 2 a.m. during college and medical school, cramming in massive amounts […] The post Why we should go with the flow of our biological clocks appeared first on Multiple Sclerosis News Today ..read more